We are live on ! Find out more
VAM

Visium Asset Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 3.58%
This Fund
S&P 500
This Quarter Est. Return
+11.95%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.41B
AUM Growth
+$131M
Cap. Flow
-$472M
Cap. Flow %
-10.71%
Top 10 Hldgs %
31.99%
Holding
983
New
316
Increased
242
Reduced
174
Closed
237

Top Buys

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$145M
2
AMGN icon
Amgen
AMGN
+$84.8M
3
PRGO icon
Perrigo
PRGO
+$60.8M
4
THC icon
Tenet Healthcare
THC
+$53.5M
5
CAH icon
Cardinal Health
CAH
+$41.2M

Top Sells

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$132M
2
ENDP
Endo International plc
ENDP
+$80.9M
3
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
+$65M
4
ESRX
Express Scripts Holding Company
ESRX
+$65M
5
GILD icon
Gilead Sciences
GILD
+$51.3M

Sector Composition

Rank Sector Weight
1 Healthcare 52.02%
2 Consumer Staples 4.24%
3 Consumer Discretionary 4.22%
4 Industrials 3.96%
5 Utilities 2.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGN
1
DELISTED
Allergan Inc
AGN
$252M 5.71%
2,781,620
+1,611,620
+138% +$145M
CAH icon
2
Cardinal Health
CAH
$53.9B
$236M 5.36%
4,529,767
+811,832
+22% +$41.2M
PRGO icon
3
Perrigo
PRGO
$1.4B
$203M 4.61%
1,647,620
+487,109
+42% +$60.8M
WCRX
4
DELISTED
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
$160M 3.63%
6,996,098
-1,997,266
-22% -$42.2M
ENDP
5
DELISTED
Endo International plc
ENDP
$127M 2.87%
2,785,861
-2,011,815
-42% -$80.9M
AGN
6
DELISTED
Allergan plc
AGN
$104M 2.36%
723,793
-105,535
-13% -$14.1M
AVP
7
DELISTED
Avon Products, Inc.
AVP
$90.6M 2.05%
4,397,258
+986,510
+29% +$21.1M
GILD icon
8
Gilead Sciences
GILD
$162B
$88.9M 2.02%
1,414,109
-857,932
-38% -$51.3M
AMGN icon
9
Amgen
AMGN
$208B
$88.3M 2%
788,547
+782,376
+12,678% +$84.8M
HCA icon
10
HCA Healthcare
HCA
$87.2B
$61M 1.38%
1,427,399
+472,210
+49% +$18.5M
WCG
11
DELISTED
Wellcare Health Plans, Inc.
WCG
$56.8M 1.29%
814,094
+78,269
+11% +$5.01M
ESRX
12
DELISTED
Express Scripts Holding Company
ESRX
$56.1M 1.27%
908,025
-1,005,808
-53% -$65M
HYG icon
13
CALL
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$55.5M 1.26%
+6,062
New +$556K
THC icon
14
Tenet Healthcare
THC
$20.5B
$53.5M 1.21%
1,298,331
+1,279,439
+6,772% +$53.5M
ICPT
15
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$52.9M 1.2%
767,015
+156
+0% +$7.7K
RPRX
16
DELISTED
Repros Therapeutics Inc.
RPRX
$48.9M 1.11%
1,825,000
– –
PCRX icon
17
Pacira BioSciences
PCRX
$1.04B
$47.4M 1.07%
985,000
-1,025,000
-51% -$37.4M
SPY icon
18
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$47.4M 1.07%
281,681
+172,739
+159% +$29M
HR icon
19
Healthcare Realty
HR
$7.28B
$45.2M 1.02%
2,148,154
+648,154
+43% +$14M
DOC icon
20
Healthpeak Properties
DOC
$15.1B
$44.4M 1.01%
1,189,202
-161,071
-12% -$6.28M
ZBH icon
21
Zimmer Biomet
ZBH
$18.2B
$43.1M 0.98%
540,958
+191,947
+55% +$15.1M
GRFS
22
Grifois
GRFS
$5.36B
$38.2M 0.87%
2,521,118
-1,317,754
-34% -$20.5M
BKD icon
23
Brookdale Senior Living
BKD
$3.49B
$37.5M 0.85%
+1,426,060
New +$39.1M
SLXP
24
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$36.8M 0.83%
+550,000
New +$37.9M
MED icon
25
Medifast
MED
$109M
$36.3M 0.82%
1,350,000
+100,000
+8% +$2.67M
1
2 3 4 5

Similar funds

FBNAT
FirstMerit Bank N.A. Trustee Akron, Ohio $1.24B AUM 5.12% 1-Year Est. Return
CPS
Counsel Portfolio Services Mississauga, Ontario, Canada $1.01B AUM 2.83% 1-Year Est. Return
LH
Lebenthal Holdings New York $806M AUM 2.13% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
ZA
Zweig Advisers Hartford, Connecticut $586M AUM 1.34% 1-Year Est. Return
FVFIGP
Flagship Ventures Fund IV General Partner Cambridge, Massachusetts $585M AUM
WA
Westport Advisers Westport, Connecticut $542M AUM 2.07% 1-Year Est. Return

Visium Asset Management's Q3 2013 Portfolio in Review

As of Q3 2013, Visium Asset Management held 983 positions worth $4.41B, up 3.1% from $4.28B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Visium Asset Management withdrew a net $472M in Q3 2013, closing 237 positions and reducing 174 holdings. Its most notable exit was Bausch Health, an estimated $132M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 48% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, Visium Asset Management opened a new position in Brookdale Senior Living worth $37.5M.

  • Visium Asset Management's largest Q3 2013 buy was Brookdale Senior Living: 1,426,060 shares worth $37.5M.
  • Visium Asset Management added most to Allergan Inc in Q3 2013, an estimated $145M increase.
  • Visium Asset Management's biggest Q3 2013 reduction was Endo International plc, cutting an estimated $80.9M.
  • Visium Asset Management fully exited Bausch Health in Q3 2013, selling an estimated $132M.
  • Visium Asset Management's ten largest holdings make up 32% of its $4.41B portfolio in Q3 2013.
  • Visium Asset Management opened 316 new positions and closed 237 in Q3 2013.
  • Visium Asset Management's portfolio value rose 3.1% quarter-over-quarter to $4.41B.

Based on Visium Asset Management's 13F filing for Q3 2013, filed 14 Nov 2013.